Artiva Biotherapeutics (ARTV) Shares Outstanding (2023 - 2025)
Historic Shares Outstanding for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $24.5 million.
- Artiva Biotherapeutics' Shares Outstanding rose 106.13% to $24.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.5 million, marking a year-over-year increase of 106.13%. This contributed to the annual value of $24.3 million for FY2024, which is 289986.01% up from last year.
- Per Artiva Biotherapeutics' latest filing, its Shares Outstanding stood at $24.5 million for Q3 2025, which was up 106.13% from $24.4 million recorded in Q2 2025.
- Artiva Biotherapeutics' Shares Outstanding's 5-year high stood at $24.5 million during Q3 2025, with a 5-year trough of $805199.0 in Q2 2023.
- Over the past 3 years, Artiva Biotherapeutics' median Shares Outstanding value was $14.0 million (recorded in 2024), while the average stood at $12.9 million.
- Over the last 5 years, Artiva Biotherapeutics' Shares Outstanding had its largest YoY gain of 290869.14% in 2025, and its largest YoY loss of 106.13% in 2025.
- Quarter analysis of 3 years shows Artiva Biotherapeutics' Shares Outstanding stood at $809758.0 in 2023, then skyrocketed by 2899.86% to $24.3 million in 2024, then grew by 1.04% to $24.5 million in 2025.
- Its last three reported values are $24.5 million in Q3 2025, $24.4 million for Q2 2025, and $24.4 million during Q1 2025.